Pinto Joshua
President
Pinto Joshua has filed 2 SEC Form 4 filings (2 transaction rows) across 2 companies, including NMRA, MTSR, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 19, 2026.
On the most recent filing, Pinto Joshua is listed as President at Neumora Therapeutics, Inc. Inside the rolling window, Pinto Joshua reported no open-market purchases and 1 open-market sale totaling $21K in NMRA.
Companies traded
Other insiders at NMRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pinto Joshua made?
Pinto Joshua has filed 2 SEC Form 4 filings (2 transaction rows) across 2 companies, including NMRA, MTSR since 2025.
Which companies does Pinto Joshua trade?
Pinto Joshua has filed SEC Form 4 disclosures for 2 companies, including NMRA, MTSR.
When was Pinto Joshua's most recent SEC Form 4 filing?
Pinto Joshua's most recent SEC Form 4 filing on Tracefour is dated Feb 19, 2026.
What is Pinto Joshua's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pinto Joshua is listed as President.
What is Pinto Joshua's total buy and sell value in the current window?
Inside the rolling retention window, Pinto Joshua bought $0 and sold $21K based on SEC Form 4 filings.
What was Pinto Joshua's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,967 NMRA shares on 2026-02-17, worth $21K, per SEC Form 4 filings.